Algorithms
Unique proprietary algorithms, which enable automated image processing for identifying and registering skin moles.
Analytics
Utilising big data and predictive analytics to provide physicians with real time data on patients’ skin, history and changes in moles or lesions.
Automated
Automated skin mole registration and anchoring together with multidimensional database for documentation and real-time retrieval.
Power
Harnessing the power of crowdsourcing of skin imaging and Cloud Computing for dermatologists, providing a low cost, user-friendly end-user interface.
About DermaCompare
DermaCompare is a revolutionary skin cancer screening platform that enables physicians to identify and monitor changes in their patients’ skin characteristics. DermaCompare was developed by Emerald Medical Applications, a digital health startup. Emerald specialises in image processing software infrastructure solutions for an extensive range of applications for diverse medical unmet needs. Emerald’s technology utilizes the knowledge of military image processing and big data analytics to improve the analysis of medical images for the benefit of patients and the medical community alike.
The challenge
The detection of skin cancer in its early stages is crucial for patient survival Dermatologists around the world are still using manual techniques, which are time consuming expensive and inaccurate. The last innovation in this field was adopted by dermatologists about fifteen years ago and it is called Total Body Photography (TBP). TBP is a set of 25 photos that cover the entire skin surface of the patient. Dermatologists recommended doing TBP every year, comparing the photographs and detecting the key differences. This solution is still very inaccurate because the human skin is dynamic, constantly moving and changing. Consequently a manual diagnostic procedure is both limited and expensive, and thus Inaccessible to most of the population.


THE SOLUTION
Our technology originated from the concepts applied by the Israeli Air Force and the intelligence services who use auto aerial photo diagnostics to track collateral damage after engaging the enemy. This means that the technology has the ability to detect and compare changes in imagery and then conduct analysis and comparison at a very high precision level. This technology and ability are responsible for the fact that missiles can hit targets that are hundreds of miles away. Now Emerald has applied it to facilitate the early detection and diagnostics of skin cancer, in order to both prevent and cure it. It has subsequently been upgraded by the Emerald development staff to improve performance even further. DermaCompare applies innovative technology focusing on these key elements:
1. Easy to use off the shelve imaging technologies (every smartphone or digitalcamera)
2. Unique proprietary algorithms, which enable automated image processing for identifying and registering skin moles. These can be pictured by any kind of camera including that inside a mobile phone.
3. Automated skin mole registration and anchoring together with a multidimensional database for documentation and real-time retrieval of data regarding skin moles and lesions.
4. Utilizing big data and predictive analytics to provide physicians with real time data on patients’ skin, history and changes in moles or lesions.
5. Harnessing the power of crowdsourcing of skin imaging and Cloud Computing for dermatologists, providing a low cost, user-friendly end-user interface.
Take a look at our videos
SKIN CANCER FAQ’S
SKIN CANCER ?
Skin cancers are a common and usually low-grade malignant growth of the skin cells. Skin cancer usually starts from cells that begin as normal skin cells and transform into abnormal cells that have the ability grow in an uncontrolled manor. The majority of skin cancers do not have the potential to metastasize to other parts of the body and threaten the patient’s life.
Skin cancers divide in to three types: the two most common types being basal cell carcinoma and squamous cell carcinoma. The third kind is called melanoma and it is less common, although more dangerous, than the other two varieties.
MELANOMA ?
Don't Be Shy
If we didn’t answer all of your questions, feel free to drop us a line anytime.